← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2012Last known activity
Oct 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05657652CollaboratorN/AOct 1, 2022
- NCT05657639CollaboratorPhase 2Oct 1, 2022
- NCT05940961CollaboratorPhase 2Aug 1, 2022
- NCT05376111CollaboratorPhase 2Apr 1, 2022
- NCT05566054CollaboratorPhase 2Mar 1, 2022
- NCT05149378CollaboratorPhase 2Nov 1, 2021
- NCT05901974CollaboratorPhase 2Jul 1, 2021
- NCT05470777CollaboratorPhase 1/Phase 2Jan 19, 2020
- NCT03309501CollaboratorPhase 3Sep 12, 2017
- NCT01274936CollaboratorPhase 2Mar 1, 2012
Details
- Last known activity
- Oct 1, 2022